{"id":"https://openalex.org/W3112196236","doi":"https://doi.org/10.1186/s13045-020-01012-y","title":"GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma","display_name":"GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma","alternate_titles":[],"publication_year":2020,"publication_date":"2020-12-01","ids":{"openalex":"https://openalex.org/W3112196236","doi":"https://doi.org/10.1186/s13045-020-01012-y","mag":"3112196236","pmid":"https://pubmed.ncbi.nlm.nih.gov/33303017","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7731630"},"language":"en","primary_location":{"id":"doi:10.1186/s13045-020-01012-y","doi":"https://doi.org/10.1186/s13045-020-01012-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13045-020-01012-y","pdf_url":"https://jhoonline.biomedcentral.com/track/pdf/10.1186/s13045-020-01012-y","source":{"id":"https://openalex.org/S46507181","display_name":"Journal of Hematology & Oncology","issn_l":"1756-8722","issn":["1756-8722"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hematology &amp; Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3112196236"],"child_works_count":2,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jhoonline.biomedcentral.com/track/pdf/10.1186/s13045-020-01012-y","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014211951","display_name":"Jeong Ah Park","orcid":"https://orcid.org/0000-0003-3690-6747","observed_orcids":["https://orcid.org/0000-0003-3690-6747"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeong A. Park","raw_affiliation_strings":["Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 170, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 170, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034081882","display_name":"Nai\u2010Kong V. Cheung","orcid":"https://orcid.org/0000-0001-6323-5171","observed_orcids":["https://orcid.org/0000-0001-6323-5171"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Nai-Kong V. Cheung","raw_affiliation_strings":["Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 170, New York, NY, USA. cheungn@mskcc.org","Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 170, New York, NY, USA"],"raw_orcid":"https://orcid.org/0000-0001-6323-5171","affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 170, New York, NY, USA. cheungn@mskcc.org","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 170, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5034081882"],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":{"value":3790,"currency":"USD","value_usd":3790},"apc_paid":{"value":3790,"currency":"USD","value_usd":3790},"fwci":3.6182,"has_fulltext":true,"cited_by_count":94,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.95004999,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"13","issue":"1","first_page":"172","last_page":"172"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.415800005197525,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.415800005197525,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.19460000097751617,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.1607999950647354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":0.9620000123977661},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.8899999856948853},{"id":"https://openalex.org/keywords/t-cell-engaging-antibody","display_name":"T cell-engaging antibody","score":0.671999990940094},{"id":"https://openalex.org/keywords/gd2","display_name":"GD2","score":0.9879999756813049},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ex-vivo-t-cell-engineering","display_name":"ex vivo T cell engineering","score":0.6890000104904175},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8159999847412109},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.9350000023841858},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.8830000162124634},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9290000200271606},{"id":"https://openalex.org/keywords/t-cell-mediated-cytotoxicity","display_name":"T cell cytotoxicity","score":0.7990000247955322},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9190000295639038},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6639999747276306}],"concepts":[{"id":"https://openalex.org/C2777760704","wikidata":"https://www.wikidata.org/wiki/Q549534","display_name":"Osteosarcoma","level":2,"score":0.7891502380371094},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6356053352355957},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6073243618011475},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5666696429252625},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.44775599241256714},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3577730357646942},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32632362842559814},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1477784514427185},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D005732","descriptor_name":"Gangliosides","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D005732","descriptor_name":"Gangliosides","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/s13045-020-01012-y","doi":"https://doi.org/10.1186/s13045-020-01012-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13045-020-01012-y","pdf_url":"https://jhoonline.biomedcentral.com/track/pdf/10.1186/s13045-020-01012-y","source":{"id":"https://openalex.org/S46507181","display_name":"Journal of Hematology & Oncology","issn_l":"1756-8722","issn":["1756-8722"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hematology &amp; Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7731630","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7731630/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Hematol Oncol","raw_type":"Text"},{"id":"pmid:33303017","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33303017","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of hematology & oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:ea57a6a6db2a4034a1d255746ffb9b03","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ea57a6a6db2a4034a1d255746ffb9b03","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-16 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s13045-020-01012-y","doi":"https://doi.org/10.1186/s13045-020-01012-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13045-020-01012-y","pdf_url":"https://jhoonline.biomedcentral.com/track/pdf/10.1186/s13045-020-01012-y","source":{"id":"https://openalex.org/S46507181","display_name":"Journal of Hematology & Oncology","issn_l":"1756-8722","issn":["1756-8722"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hematology &amp; Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2538737708","display_name":null,"funder_award_id":"P30 CA008748","funder_id":"https://openalex.org/F4320338333","funder_display_name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute"},{"id":"https://openalex.org/G9000856728","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA008748","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320319745","display_name":"Y-mAbs Therapeutics","ror":"https://ror.org/03mj3df16"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320338333","display_name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","ror":"https://ror.org/00vkwep27"},{"id":"https://openalex.org/F567038011","display_name":"Robert K Steel Family Foundation","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3112196236.pdf","grobid_xml":"https://content.openalex.org/works/W3112196236.grobid-xml"},"referenced_works_count":64,"referenced_works":["https://openalex.org/W31753021","https://openalex.org/W1458549199","https://openalex.org/W1832334802","https://openalex.org/W1936567301","https://openalex.org/W1959582193","https://openalex.org/W1964109131","https://openalex.org/W1975848200","https://openalex.org/W1980895192","https://openalex.org/W2000677573","https://openalex.org/W2009888206","https://openalex.org/W2010256904","https://openalex.org/W2011944525","https://openalex.org/W2014789164","https://openalex.org/W2016983859","https://openalex.org/W2017624163","https://openalex.org/W2021591934","https://openalex.org/W2024524568","https://openalex.org/W2025240311","https://openalex.org/W2026537544","https://openalex.org/W2027845878","https://openalex.org/W2041466047","https://openalex.org/W2045574406","https://openalex.org/W2048345613","https://openalex.org/W2051836910","https://openalex.org/W2055916341","https://openalex.org/W2077871666","https://openalex.org/W2095599995","https://openalex.org/W2097608507","https://openalex.org/W2100033620","https://openalex.org/W2103405666","https://openalex.org/W2108902851","https://openalex.org/W2115160785","https://openalex.org/W2117706207","https://openalex.org/W2128486176","https://openalex.org/W2135135005","https://openalex.org/W2135915203","https://openalex.org/W2136399690","https://openalex.org/W2138582752","https://openalex.org/W2157003991","https://openalex.org/W2219506342","https://openalex.org/W2258061020","https://openalex.org/W2314452004","https://openalex.org/W2342423058","https://openalex.org/W2428642147","https://openalex.org/W2553835169","https://openalex.org/W2594312824","https://openalex.org/W2671688469","https://openalex.org/W2726935839","https://openalex.org/W2745455975","https://openalex.org/W2747769029","https://openalex.org/W2758151211","https://openalex.org/W2768550677","https://openalex.org/W2774372124","https://openalex.org/W2803369586","https://openalex.org/W2806230676","https://openalex.org/W2866443759","https://openalex.org/W2885155365","https://openalex.org/W2896389733","https://openalex.org/W2952737707","https://openalex.org/W2965782443","https://openalex.org/W2976924121","https://openalex.org/W2980897730","https://openalex.org/W2995486427","https://openalex.org/W3006860236"],"related_works":["https://openalex.org/W2988363250","https://openalex.org/W2912089449","https://openalex.org/W1513821330","https://openalex.org/W3012852782","https://openalex.org/W2322679988","https://openalex.org/W2740477084","https://openalex.org/W2078611218","https://openalex.org/W1965806238"],"abstract_inverted_index":{"Background":[0],"The":[1],"cure":[2],"rate":[3],"for":[4,23],"metastatic":[5,24],"osteosarcoma":[6,27,46,84,119,160,175,255],"has":[7],"not":[8,29],"substantially":[9],"improved":[10,208],"over":[11],"the":[12,125,214,234],"past":[13],"decades.":[14],"Clinical":[15],"trials":[16],"of":[17,76,156,213,237],"anti-HER2":[18,168,224],"trastuzumab":[19],"or":[20,25,80,87,132,143,167,188],"anti-GD2":[21],"dinutuximab":[22],"refractory":[26],"were":[28,137,151,226],"successful,":[30],"and":[31,52,113,149,163,179,207,211,219,223,239],"neither":[32],"was":[33],"immune":[34,247],"checkpoint":[35,248],"inhibitors":[36],"(ICIs).":[37],"Methods":[38],"We":[39,70,104],"tested":[40,71,138],"various":[41],"target":[42],"antigen":[43],"expressions":[44],"on":[45,159],"cell":[47,57,85,161,203],"lines":[48,162],"using":[49,64],"flow":[50],"cytometry":[51],"analyzed":[53],"in":[54,72,82,95,177,180,205,228,244,252],"vitro":[55,178],"T":[56,61,110,182,202],"engaging":[58],"BsAb":[59,166,169],"(T-BsAb)-dependent":[60],"cell-mediated":[62],"cytotoxicity":[63],"4-h":[65],"51":[66],"Cr":[67],"release":[68],"assay.":[69],"vivo":[73,108,206],"anti-tumor":[74,126,172,193],"activities":[75,194],"T-BsAb":[77,242],"targeting":[78],"GD2":[79,148,238],"HER2":[81,150,240],"established":[83],"line":[86],"patient-derived":[88],"xenograft":[89],"(PDX)":[90],"mouse":[91],"models":[92],"carried":[93],"out":[94],"BALB-":[96],"Rag2":[97],"\u2212/\u2212":[98],"IL-2R-":[99],"\u03b3c":[100],"-KO":[101],"(BRG)":[102],"mice.":[103],"also":[105],"generated":[106],"ex":[107],"BsAb-armed":[109,201],"cells":[111,183],"(EATs)":[112],"studied":[114],"their":[115,139,258],"tumor-suppressive":[116],"effect":[117,173],"against":[118,145,174],"xenografts.":[120],"In":[121],"order":[122],"to":[123,256],"improve":[124,257],"response,":[127],"ICIs,":[128],"anti-human":[129,133],"PD-1":[130],"(pembrolizumab)":[131],"PD-L1":[134],"(atezolizumab)":[135],"antibodies":[136],"synergy":[140],"with":[141,185,246,254],"GD2-":[142],"HER2-BsAb":[144],"osteosarcoma.":[146,230],"Results":[147],"chosen":[152],"from":[153],"a":[154],"panel":[155],"surface":[157],"markers":[158],"PDXs.":[164],"Anti-GD2":[165,222],"exerted":[170],"potent":[171],"tumors":[176],"vivo.":[181],"armed":[184],"anti-GD2-BsAb":[186],"(GD2-EATs)":[187],"anti-HER2-BsAb":[189],"(HER2-EATs)":[190],"showed":[191],"significant":[192],"as":[195],"well.":[196],"Anti-PD-L1":[197],"combination":[198,245],"treatment":[199,243,259],"enhanced":[200],"function":[204],"tumor":[209],"control":[210],"survival":[212],"mice,":[215],"when":[216],"given":[217],"sequentially":[218],"continuously.":[220],"Conclusion":[221],"BsAbs":[225],"effective":[227],"controlling":[229],"These":[231],"data":[232],"support":[233],"clinical":[235],"investigation":[236],"targeted":[241],"inhibitors,":[249],"particularly":[250],"anti-PD-L1,":[251],"patients":[253],"outcome.":[260]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3112196236","counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":16},{"year":2024,"cited_by_count":25},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":15}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2020-12-21T00:00:00"}
